Advertisement

Topics

Lightspeed Venture Partners Company Profile

13:32 EDT 24th September 2018 | BioPortfolio

The partners of Lightspeed have invested over $800M in more than 100 technology companies over the past two decades. Our team invests in the U.S., Israel and Asia and has contributed strong operational and sector expertise to market leaders such as Blue Nile, Brocade, Ciena, eHealthinsurance, Galileo Technology, Informatica, Kiva Software, Metasolv, Phone.com, Quantum Effect Devices, Sirocco and Waveset, working closely with these companies throughout the early stages of their business development lifecycles. Because we focus on investments in specific sectors, portfolio companies benefit from Lightspeed's specialized industry knowledge and deep global network of relationships. Areas of investment focus include the following:Datacenter Infrastructure
Enterprise Automation
Digital Media and Consumer Electronics
Communications Infrastructure
Internet and E-Commerce
Wireless Applications
Semiconductors
Emerging Technologies
Lightspeed's hallmark is lead early stage investing, including an active seed investment program. We are proud of the fact that a number of executives with whom we have partnered in the past have chosen Lightspeed as the lead investor for their subsequent ventures.

Location

2200 Sand Hill Road
Menlo Park,
California
94025
United States of America

Contact

Phone: 650.234.8300
Fax: 650.234.8333
Email: info@lightspeedvp.com


News Articles [414 Associated News Articles listed on BioPortfolio]

ASTRO 2014: Proton therapy's lightspeed promise

ASTRO 2014: Proton therapy's lightspeed promise kmahdoubi Wed, 09/17/2014 - 19:23

Series B brings in $40mm for OncoResponse

OncoResponse Inc. (cancer immunotherapies) raised $40mm through its Series B round, which was led by RiverVest Venture Partners and included investments by first-time buyers Qatar Investment Authority...

GBS Venture Partners: Joshua Funder on seeing positive signs in the Australian biotech sector.

In this episode of PharmaTelevision News Review, Fintan Walton talks to Joshua Funder, Partner at GBS Venture Partners

Bruker Introduces Contour LS-K 3D Optical Profiler

The LightSpeed focus variation method is ideal for surfaces with significant roughness, large step heights, or steep angles and is a perfect complement to the Read more...

Magnolia Neurosciences launches with $31mm Series A round

With a $31mm Series A round, Accelerator Life Science Partners launched Magnolia Neurosciences Corp. (neuroprotective therapeutics). Participants in the financing included AbbVie Ventures, Alexandria ...

Geoff Brooke, Co-founder & Managing Partner at GBS Venture Partners

In this episode of PharmaTelevision News Review, filmed at AusBio 2012 in Melbourne, Australia, Fintan Walton talks to Geoff Brooke, Co-founder & Managing Partner at GBS Venture Partners

New Leaf Venture Partners looks to raise $275M for 4th fund

A proposal to raise up to $275 million was filed by New Leaf Venture Partners with the SEC for its New Leaf Ventures IV fund. -More- 

Metacrine closes $65mm Series C

Metacrine Inc. (therapies for hepatic, gastrointestinal, and metabolic diseases) raised $65mm in its Series C financing led by Venrock Healthcare Partners, which was joined by first-time backers Frank...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [246 Associated PubMed Articles listed on BioPortfolio]

Evaluating a psychosocial intervention for men with prostate cancer and their partners: Outcomes and lessons learned from a randomized controlled trial.

This study evaluated the process and outcome of a psychosocial intervention for men with prostate cancer and their partners. As more men survive prostate cancer, they and their partners need help and ...

Impact of HIV Self-Test Distribution to Male Partners of ANC Clients: Results of a Randomized Controlled Trial in Kenya.

In Kenya, HIV testing during first ANC visit is standard practice for pregnant women. Despite a policy promoting male partner testing in ANC, few male partners accompany their partners for HIV testing...

What Does it Need to Improve Nutrition Quality? The Role of Public Partners.

Public partners play a key role when we want to improve nutrition quality. They will not succeed, when they try to achieve the goal alone or tend to dominate other players. In their responsibility for...

How Patient Partners Influence Quality Improvement Efforts.

There is growing acknowledgement that patients are key stakeholders in improving quality of medical care, yet a key barrier to integrating patients into quality improvement teams (QITs) as patient par...

Prevalence of HIV infection, access to HIV care, and response to antiretroviral therapy among partners of HIV-infected individuals in Thailand.

Health care providers usually focus on index HIV-infected patients and seldom obtain information from their partners. We aimed to determine HIV-preventative measures among couples, the prevalence of H...

Clinical Trials [324 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

A Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT

To compare computed tomography (CT) images (pictures) of the coronary arteries using the General Electric (GE) LightSpeed VCT scanner with x-ray coronary angiography in patients referred f...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Companies [1632 Associated Companies listed on BioPortfolio]

Lightspeed Venture Partners

The partners of Lightspeed have invested over $800M in more than 100 technology companies over the past two decades. Our team invests in the U.S., Israel and Asia and has contributed strong operationa...

Stromedix, Inc.

Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrotic organ failure. Investors in Stromedix include A...

Direct Flow Medical, Inc.

Founded in 2004, the Company is headquartered in Santa Rosa, California, has a second manufacturing facility in Lake Forest, CA and employs 75 people. The Company’s unique im...

Hatteras Venture Partners

Hatteras Venture Partners (HVP) is a venture capital firm based in Research Triangle Park, NC with a focus on seed and early stage opportunities in biopharmaceuticals, medical dev...

DN Venture Partners

DN Venture Partners is a dedicated consulting firm committed to providing effective and timely business development support services. We focus on helping technology-based organisations to expand their...

More Information about "Lightspeed Venture Partners" on BioPortfolio

We have published hundreds of Lightspeed Venture Partners news stories on BioPortfolio along with dozens of Lightspeed Venture Partners Clinical Trials and PubMed Articles about Lightspeed Venture Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lightspeed Venture Partners Companies in our database. You can also find out about relevant Lightspeed Venture Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record